T-cell therapy, originally developed for haematological malignancies, has recently emerged as a promising therapy for ...

Clinicians may one day be able to treat immune checkpoint inhibitor-related myocarditis without disrupting cancer therapy, findings from a cellular investigation showed.Individuals who die of immune ...

Chimeric antigen receptor-T (CAR-T) cell therapy, initially successful in hematologic malignancies, presents a promising avenue for treating solid tumors, including CRC. This review explores the ...

CAR T-cell therapy is an advanced immunotherapy that harnesses the power of a patient’s own immune cells, specifically ...

VMMC and Safdarjung Hospital successfully performed their inaugural CAR-T cell therapy for cancer treatment, marking a ...

Caregiving can take many forms, often requiring a profound shift in daily life. While navigating a disease is an immense ...

A new research paper was published in Oncotarget's Volume 16 on January 20, 2025, titled "Anti-correlation of KLRG1 and PD-1 expression in human tumor CD8 T cells." ...

Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the ...

Researchers believe the innovative idea holds immense promise for tackling a wide range of diseases including cancer through ...

Some of those patients will experience refractory cancer – cancer that does not respond to initial treatment or becomes ...